Login
Toggle navigation
Videos
Categories
Trending
Unlocking Potential: Noront Resources Ltd. | Alan Coutts - CEO of Noront Resources.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alan Coutts is the CEO of Noront Resources.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Investment Dollars and Impact Initiatives for an Inclusive Economy | U.S. Small Business Administration (SBA)
00:10:00
Rumble Resources Expands High-Grade Gold Potential at Western Queen Project
00:10:00
Bill Keffer Discusses Financial Planning with Marie Swift at NAPFA Midwest Symposium, July 2012
00:10:00
Passed on B2B Companies at Seed and Pre Seed Funding|Amanda Robson,Partner,Cowboy Ventures
00:10:00
CN Railway Highlights Growth and Opportunities in Saskatchewan's Transport Network
00:10:00
BC Partners Europe Chairman Nikos Stathopoulos Discusses Preparing for Recession | Nikos Stathopoulos, Chairman, BC Partners.
00:10:00
We are a community built on care|Saum Sutaria, Chief Executive Officer, Tenet
00:10:00
Insights into French Biotech: Challenges and Opportunities in Healthcare Innovation Explored by Industry Expert | André Choulika, CEO,Cellectis SA.
00:10:00
CEO of JLL Discusses Global Office Trends, Adaptation Strategies, and Real Estate Evolution | Christian Ulbrich, CEO, JLL Partners.
00:10:00
Greg Foran on Leading Air New Zealand Through Turbulence and His Vision for the Future | Greg Foran, CEO, Air New Zealand Ltd .
00:00:00
ReNeuron / Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
Adelene Pewrkins, CEO, Infinity Pharmaceuticals Inc